Journal Article10.1152/JAPPLPHYSIOL.00162.2013
Muscle dysfunction in COPD
TL;DR: Interestingly, while hyperinflation and an increased work of breathing appear to be the main contributing events to respiratory muscle dysfunction, deconditioning seems to play a major role in the dysfunction of peripheral muscles in COPD.
read more
Abstract: Although it has been well characterized that COPD muscle dysfunction is the result of the complex interaction between systemic and local factors, the etiology of muscle dysfunction remains to be fully identified. Interestingly, while hyperinflation and an increased work of breathing appear to be the main contributing events to respiratory muscle dysfunction, deconditioning seems to play a major role in the dysfunction of peripheral muscles in COPD. Other factors such as cigarette smoke, nutritional abnormalities, exacerbations, drugs, hypoxia, hypercapnia, comorbidities, and physical activity also influence muscle mass and function in COPD patients (1-3; 5; 9; 15). Besides, derangements of key molecular and cellular processes such as redox imbalance, mitochondrial dysfunction, enhanced protein catabolism and reduced protein anabolism, structural alterations, and systemic inflammation also modify muscle phenotype and function in COPD patients.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
Respiratory and Limb Muscle Dysfunction in COPD
Esther Barreiro,Joaquim Gea +1 more
TL;DR: It is claimed that body composition and quadriceps muscle strength should be routinely explored in COPD patients in clinical settings, even at early stages of their disease.
158
High CO2 Levels Cause Skeletal Muscle Atrophy via AMP-activated Kinase (AMPK), FoxO3a Protein, and Muscle-specific Ring Finger Protein 1 (MuRF1)
Ariel Jaitovich,Martín Angulo,Emilia Lecuona,Laura A. Dada,Lynn C. Welch,Yuan Cheng,Galina A. Gusarova,Ermelinda Ceco,Chang Liu,Masahiko Shigemura,Esther Barreiro,Cam Patterson,Gustavo A. Nader,Jacob I. Sznajder +13 more
TL;DR: Evidence is provided that high CO2 activates skeletal muscle atrophy via AMPKα2-FoxO3a-MuRF1, which is of biological and potentially clinical significance in patients with lung diseases and hypercapnia.
109
Screening of long non-coding RNA and TUG1 inhibits proliferation with TGF-β induction in patients with COPD.
TL;DR: Abundant, differentially expressed lncRNAs and mRNAs were identified by microarray analysis and these might play a partial or key role in the diagnosis of patients with COPD.
63
Moving Towards Patient-Centered Medicine for COPD Management: Multidimensional Approaches versus Phenotype-Based Medicine—A Critical View
TL;DR: Although these approaches are not perfect, they represent the first step towards patient-centered medicine for COPD and should converge towards one new field to focus on the better management of COPD patients.
31
Does Whole-Body Vibration Improve the Functional Exercise Capacity of Subjects With COPD? A Meta-Analysis
Adriane Borba Cardim,Patrícia Érika de Melo Marinho,Jasiel Nascimento,Helen Kb Fuzari,Armèle Dornelas de Andrade +4 more
TL;DR: Whole-body vibration seems to benefit subjects with COPD by improving their functional exercise capacity, without producing adverse effects, and the quality of evidence is moderate, but the degree of recommendation is strong.
26
References
Peripheral muscle weakness contributes to exercise limitation in COPD.
TL;DR: It is concluded that lung function and peripheral muscle force are important determinants of exercise capacity in COPD.
1K
Midthigh Muscle Cross-Sectional Area Is a Better Predictor of Mortality than Body Mass Index in Patients with Chronic Obstructive Pulmonary Disease
Karine Marquis,Richard Debigaré,Yves Lacasse,Pierre LeBlanc,Jean Jobin,Guy Carrier,François Maltais +6 more
TL;DR: It is found that a reduction in midthigh muscle cross-sectional area obtained by CT scan is a better predictor of mortality than BMI, and MTCSA had a strong impact on mortality in patients with an FEV(1) < 50% predicted.
886
Quadriceps strength predicts mortality in patients with moderate to severe Chronic Obstructive Pulmonary Disease
Elisabeth B. Swallow,Diana Reyes,Nicholas S Hopkinson,William D.-C. Man,Raphaël Porcher,Edward J. Cetti,Alastair J. Moore,John Moxham,Michael I. Polkey +8 more
TL;DR: QMVC is simple and provides more powerful prognostic information on COPD than that provided by age, body mass index and forced expiratory volume in 1 s.
787
The prevalence of quadriceps weakness in COPD and the relationship with disease severity
John Seymour,Martijn A. Spruit,Nicholas S Hopkinson,Samantha A. Natanek,W D-C Man,A. Jackson,Harry R. Gosker,Annemie M. W. J. Schols,John Moxham,Michael I. Polkey,Emiel F.M. Wouters +10 more
TL;DR: The prevalence of weakness (defined as observed values 1.645 standardised residuals below predicted) was related to Global Initiative for Chronic Obstructive Lung Disease stage and Medical Research Council dyspnoea score in two cohorts of stable COPD outpatients recruited from the UK and the Netherlands.
500
Intensity of training and physiologic adaptation in patients with chronic obstructive pulmonary disease
François Maltais,Pierre LeBlanc,Jean Jobin,C Bérubé,J Bruneau,M J Breton,G Falardeau,Roger Belleau +7 more
TL;DR: It is concluded that although most patients were unable to achieve high-intensity training as defined in this study, significant improvement in their exercise capacity was obtained and physiologic adaptation to endurance training occurred.
432